ResearcherAsan Medical CenterNo recent work listed

Dok Hyun Yoon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8289-3548; OpenAlex author ID A5022379369. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2012: 2 papers

Papers 2

YM155 induces EGFR suppression in pancreatic cancer cells. Co-author DOI 10.1371/journal.pone.0038625 ↗
The survivin suppressant YM155 potentiates chemosensitivity to gemcitabine in the human pancreatic cancer cell line MiaPaCa-2. Co-author PMID 22593446 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Tae Won Kim · 2 shared papers, 2012 · strength 0.06
- Paper YM155 induces EGFR suppression in pancreatic cancer cells. DOI 10.1371/journal.pone.0038625 ↗
- Paper The survivin suppressant YM155 potentiates chemosensitivity to gemcitabine in the human pancreatic cancer cell line Mia… PMID 22593446 ↗
Jae‐Lyun Lee · 2 shared papers, 2012 · strength 0.06
- Paper YM155 induces EGFR suppression in pancreatic cancer cells. DOI 10.1371/journal.pone.0038625 ↗
- Paper The survivin suppressant YM155 potentiates chemosensitivity to gemcitabine in the human pancreatic cancer cell line Mia… PMID 22593446 ↗
Young-Soon Na · 1 shared paper, 2012 · strength 0.03
- Paper YM155 induces EGFR suppression in pancreatic cancer cells. DOI 10.1371/journal.pone.0038625 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.